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Abstract 
Probiotics are the health promoting viable microorganisms that exhibit a beneficial effect on the health of human being by 
improving the intestinal microbial balance. A total of 120 milk samples (40 each from buffalo, cow, and goat) were analyzed 
and 110 isolates were identified as Lactic Acid Bacteria (LAB). Out of these 11 isolates were identified as prominent probiotics, 
among them 3 isolates were excellent probiotics. These excellent probiotics were compared for their probiotic potential with 
commercial probiotic preparations such as Sporlac powder, LactoBacil plus, P-Biotics kid, Gastroline, Pre-Pro kid and 
standard probiotic bacterial strains L. plantarum (MTCC 2621) and L. rhamnosus (MTCC 1048). The isolated LAB exhibited 
excellent probiotic characteristics than commercial probiotic preparations and standard probiotic bacterial strains. Study 
suggested that use of these probiotic bacteria from milk of domestic animals can be help to prevent or control the intestinal 
infections and contributes health benefits to consumers. 
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Introduction 
Milk and milk products are usually associated with 
probiotic bacteria, which provide supplements in 
maintaining beneficial intestinal balance (Isolauri, 2001). 
Probiotic is the group of microbes that may help directly 
for enhancing resistance against intestinal pathogens 
and in the prevention of diseases. Probiotic bacteria 
may produce various compounds, which are inhibitory 
to the pathogen’s growth, which include organic acids 
(lactic and acetic acids), bacteriocins, and reuterin. The 
organic acids not only lower the pH, thereby affecting 
the growth of the pathogen, but they can also be toxic 
to the microbes. Lactobacilli are known to produce 
many types of bacteriocins like acidophilin, acidolin, 
lactocidin, bulgarican, lactolin, lactobacillin and 
lactobrevin (Alvarez-Olmos and Oberhelman, 2001).  
Infectious diseases are the biggest problem in 
human being and every year gastrointestinal infections 
are responsible for significant morbidity and mortality 
worldwide (Culligan et al, 2009). World Health 
Organization (WHO, 2004) estimates there to be more 
than four billion episodes of diarrhoeal disease 
annually, while there were 2.2 million deaths 
attributable to enteric infection, making it the fifth 
leading cause of death at all ages worldwide. Enteric 
bacteria comprised of Salmonella species, Shigella 
species, Proteus species, Klebsiella species, E. coli, 
Pseudomonas species, Vibrio cholerae and S. aureus 
which are major etiologic agents of enteric infection 
(Ballal and Shivananda, 2002). There is increasing 
evidence that probiotics are beneficial in 
gastrointestinal disturbances, such as diarrhoea, 
dysentery, typhoid etc (Fuller, 1991). The rise in 
antibiotic resistant bacteria has awakened the scientific 
community to the prophylactic and therapeutic uses of 
probiotics, and to reconsider them as alternatives to 
antibiotics (Ahmed, 2003).  
Various Lactobacilli, Bifidobacteria and 
Streptococcus species have been evaluated for the 
prevention or treatment of various infectious diseases 
and these were found to be safe (Chapoy, 1985). 
Various commercial probiotic preparations are also 
available in the market in the form of capsules, 
liquid/gel and powdered that claims for prevention of 
infectious diseases. Commercially available probiotic 
preparations include Lactobacillus alone (Lactiflora, 
LactoBacil, Lactocap, Lactovit, Sporlac) or in 
combination with Streptococcus (Lacticin) or 
Saccharomyces (Laviest) and showed benefical effects 
(Saggioro, 2004).  
The functional properties and safety of probiotics 
of particular strains of L. casei, L. lactis, L. acidophilus 
from various sources have been extensively studied 
and commercial probiotic preparations also claims its 
efficiency for prevention of infectious diseases, but 
probiotics potential from milk of domestic animals viz 
cow, goat and buffalo, with significance in prevention of 
enteric infection have not been reported so far. 
However, the overall efficacy of probiotics from milk of 
domestic animals and the mechanisms by which 
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probiotics ameliorate enteric infections are mostly 
unknown. Therefore the an attempt was made to 
isolate Lactobacillus strains as probiotics from milk of 
domestic animals and compared its probiotics potential 
with commercial probiotic preparations and standard 
probiotic bacterial strains in  prevention of enteric 
bacterial infections. 
 
Materials and Methods 
Isolation and identification of Lactobacillus species 
A total of 120 milk samples (40 each from cow, 
goat, and buffalo) were randomly collected in sterilized 
glass bottles. Milk was serially diluted to 10-5-10-6 using 
sterile distilled water and 0.1mL plated on to sterile de-
Mann, Rogosa and Sharpe (MRS) agar. The MRS 
plates were maintained in microaerophilic condition 
and incubated at 370C for 48h. After incubation, well-
isolated typical colonies were picked up, transferred to 
MRS broth, and incubated at 370C for 48h. The 
isolates were identified using standard morphological, 
cultural and biochemical reactions (Howells, 1992).  
 
Acid and bile salt tolerance 
Isolated Lactobacillus sp. were inoculated into 
MRS medium of varying pH, i.e. pH 2, 3, 4 and 5; as 
well as broth with varying concentrations of bile salt 
(0.5, 1.0, 1.5 and 2.0%), and incubated at 370C for 48h. 
Then 0.1mL inoculums was transferred to MRS agar by 
pour plate method and incubated at 370C for 48h. The 
growth of LAB on MRS agar plate was used to 
designate isolates as acid or bile salt tolerant.  
 
Detection of antagonistic activities 
The antagonistic properties of isolated LAB 
species were determined by modifying the disc 
diffusion method. Sterile blotting paper discs (10mm) 
were dipped into 48h incubated Lactobacillus sp. 
culture broth and then placed on solidified Nutrient 
agar seeded with 3h old culture of test pathogens, 
which included Escherichia coli (MTCC 443), 
Enterobacter aerogenes (MTCC 111), Klebsiella 
pneumoniae (MTCC 2653), Proteus vulgaris (MTCC 
426), Salmonella typhi (MTCC 734) and Shigella 
flexneri (MTCC 1457). The plates were kept at 40C for 
1h diffusion and then incubated at 370C for 24h. Zones 
of inhibition were measured (Kirby-Bauer, 1966).  
 
Antibiotic resistance 
The antibiotic resistance of isolated LAB was 
assessed using antibiotic discs (Hi media Laboratories 
Pvt. Ltd. Mumbai, India) on MRS agar plates. A 106 
cfu/mL suspension of freshly grown test organisms was 
mixed with 5mL of MRS soft agar (0.5% agar) and over 
layered on bottom layers of MRS agar. The antibiotic 
discs were placed on the surface of agar and the plates 
were kept at 40C for 1h for diffusion, and then 
incubated at 370C for 24h (Halami et al, 1999). 
Resistance was assessed against Ampicillin (1µg), 
Cephalothin (30µg), Co-Trimoxazole (25µg), 
Gentamicin (10µg), Nalidixic acid (30µg), Nitrofurantoin 
(300µg), Norfloxacin (10µg) and Tetracycline (25µg). 
 
Preparation of bacteriocin assay 
The prominent probiotic Lactobacillus strains were 
selected as potential bacteriocin producers grown in 
MRS broth at 370C for 48h. Cell suspensions were 
centrifuged at 5000 rpm for 15 min. The pH of the cell 
free supernatant was adjusted to pH 6.5-7.0 with 1N 
NaOH to neutralize the acids in broth culture of 
probiotics. The antagonistic activity of bacteriocin was 
determined by disc diffusion method (Tagg and 
McGiven, 1971). 
 
Heat and pH sensitivity 
To test the heat sensitivity, culture supernatant 
containing bacteriocin was heated for 10 min. at 600C, 
700C, 800C, 900C, 1000C and 1210C and bacteriocin 
activity was tested against E. coli. Similarly sensitivity 
of bacteriocins to different pH was tested by adjusting 
the pH of culture supernatant (containing bacteriocins) 
in the range of pH 3.0, 4.5, 7.0 and 9.0 then bacteriocin 
antibacterial activity was detected by disc diffusion 
method against E. coli (Ogunbanwo et al, 2003). 
 
Comparative study of probiotics 
Identified excellent probiotic (L. plantarum C68a, L. 
plantarum G95a, L. rhamnosus G119b) were 
compared with commercial probiotic preparations 
available in market (Sporlac powder, LactoBacil plus, 
P-Biotics Kid, Gastroline, Pre-Pro kid) and standard 
probiotic bacterial strains  (L. plantarum MTCC 2621, L. 
rhamnosus MTCC 1048) i.e. acid and bile tolerance, 
antibacterial activity, antibiotic resistance, antibacterial 
potential of bacteriocin, acid, alkali, heat tolerance of 
bacteriocin. Multiple antibiotic resistance (MAR) were 
determined as following modified formula 
 
 
      
MAR Index for 
a   antibiotics     
Number of antibiotics 
resistance isolates 
No. of antibiotics tested X No. 
of isolates 
 
Calculation of probiotic potential 
Each property of isolated probiotics from milk of 
domestic animals, commercial probiotic preparations 
and standard probiotic bacterial strains were scored as 
under 
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Probiotic characters Indication Score 
Acid, bile tolerance sensitivity, antibiotic resistant, acid/ alkali/ heat tolerance of bacteriocin  Sensitivity 0 
Resistance 1 
Antibacterial potential of probiotics (zone of inhibition of growth in mm) 14-16 mm 1 
17-20 mm 2 
> 21 mm 3 
 
 
Cumulative probiotic potential is the sum of score 
of acid, bile tolerance, antibacterial potential, acid and 
alkali and heat tolerance of bacteriocin. Probiotic 
potential was calculated as observed score divided by 
maximum score into hundred. 
 
Probiotic 
potential = 
Observed 
score X     100 Maximum 
score 
 
Results and Discussion 
In present study, a total of 120 milk samples (40 
each from Cow, Goat and Buffalo) were analyzed, from 
which 110 Lactobacillus species were identified as L. 
acidophilus (13%), L. brevis (10%), L. bulgaricus (9%), 
L. lactis (19%), L. plantarum (15%), L. rhamnosus 
(14%), L. helveticus (2%), L. casei (17%) and L. 
fermentum (1%). Out of these 11 isolates were 
recognized as probiotics and from these  3 were 
identified as a  excellent probiotics on the basis of their 
acid and bile tolerance, antibacterial activity, antibiotic 
resistance, antibacterial potential of bacteriocin, acid, 
alkali and high temperature tolerance of bacteriocin. 
These 3 best probiotics were L. rhamnosus (G119b), L. 
plantarum (G95a) from goat milk and L. plantarum 
(C68a) from cow milk were compared for their potential 
with commercial probiotic preparations and standard 
probiotic bacterial strains (Table 1).
 
 
Table 1: Comparative study of isolated probiotics from milk of domestic animals, commercial probiotic preparations and standard 
probiotic bacterial strains 
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 (C68a) R R 18 24 25 23 25 22 R R R R R R R R 21 24 25 24 27 25 R R R R R R R R R R
L. plantarum 
(G95a) R R 19 24 23 24 25 24 R R R R R R R R 22 25 25 26 27 27 R R R R R R R R R R
L. rhamnosus 
(G119b) R R 19 24 24 24 25 24 R R R R R R R R 23 25 25 26 28 27 R R R R R R R R R R
Sporlac powder R R 17 20 21 20 23 21 R R S S R S S R 21 23 23 22 25 23 R R R R S S R R R S
LactoBacil plus R R 20 20 17 19 22 18 R R R R R R R S 22 23 23 23 25 19 R R R R S S R R R S
P-Biotics Kid R R 18 20 23 22 23 20 R R R R R R R S 20 19 20 23 27 25 R R R R R S R R R S
Gastroline R R 16 16 15 17 19 18 R R R R R R S R 20 22 22 22 25 23 R R R R S S R R R S
Pre-Pro kid R R 16 20 23 25 25 22 R R R R R S S R 19 22 24 23 27 25 R R R R S S R R R S
L. plantarum  
(MTCC 2621) R R 18 20 20 22 20 19 R R R S R S R R 20 22 24 21 24 23 R R R R R S R R R S
L. rhamnosus  
(MTCC 1048) R R 16 18 18 17 20 18 R R R R R S S S 20 21 23 21 25 23 R R R R R S R R R S
Where: R=Resistant, S= Sensitive 
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Acid and Bile salt tolerance 
Probiotics potential of LAB is necessarily its ability 
to resist bile salts and acidic pH (Lee and Salminen, 
1995). In this study, three isolated excellent probiotic, 
commercial probiotic and standard probiotic bacterial 
strains showed acid tolerance at pH 2 and bile salt 
tolerance at 2%. Before reaching the intestinal tract, 
probiotic bacteria must first survive transit through the 
stomach where the pH can be as low as 1.5 to 2 
(Dunne et al, 2001). Tolerance to bile salts is a 
prerequisite for colonization and metabolic activity of 
bacteria in the small intestine of the host (Havenaar et 
al, 1992). This will help Lactobacilli to reach the small 
intestine and colon and contribute in balancing the 
intestinal microflora (Tambekar and Bhutada, 2010).  
 
 
 
Antagonistic activity 
The isolated probiotics from milk of domestic 
animals, L. rhamnosus (G119b), L. plantarum (G95a, 
C68a) were strong antagonistic  (Score 17) followed by 
commercial probiotic preparations Pre-Pro kid, P-
Biotics kid, Sporlac powder, LactoBacil plus, Gastroline 
containing probiotics (Score 9-15), standard probiotic 
bacterial strains L. plantarum (MTCC 2621), L. 
rhamnosus (MTCC 1048) (Score 11-12) against enteric 
pathogens (fig.1). This may be due to the production of 
acetic and lactic acids that lowered the pH of the 
medium or competition for nutrients, or due to 
production of bacteriocin or antibacterial compound 
(Tambekar et al, 2009; Bezkorvainy, 2001). Chuayana 
et al, (2003) reported that different milk products were 
able to inhibit the growth of S. aureus, E. coli, Ps. 
aeruginosa, S. typhi, Serratia marcescens and Candida 
albicans.
  
 
Fig. 1: Antagonistic activity of isolated probiotics, commercial probiotic preparations and standard probiotic bacterial strains against 
enteric pathogens 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: MAR Index of isolated probiotics, commercial probiotic preparations and standard probiotic bacterial strains 
 
 
 
 
 
 
 
 
 
Fig. 3: Antibacterial activity of bacteriocin produced by isolated probiotics, commercial probiotic preparations and standard probiotic 
bacterial strains 
 
 
 
 
 
 
 
 
D.H. Tambeka and S.A. Bhutada/Rec Res Sci Tech 2 (2010) 82-88 
 
 
 
Our study showed that L. rhamnosus and L. 
plantarum had strongest antagonistic potential against 
Salmonella typhi followed by Proteus vulgaris and 
Klebsiella pneumoniae. Obadina et al, (2006) also 
reported that fermentation process, which involved L. 
plantarum, had a broad antimicrobial inhibitory 
spectrum, against Salmonella typhi, E. coli, and S. 
aureus. Hence, isolated probiotics can be useful to 
prevent enteric infections such as diarrhoea, dysentery, 
typhoid, food poisoning etc.  
 
Antibiotic resistance 
Multiple antibiotic resistance (MAR) index (fig.2) of 
isolated probiotics from milk of domestic animals was 
high indicating high resistance to all antibiotics as 
compared to commercial probiotic preparations (MAR 
index 0.75-0.87) and standard probiotic bacterial 
strains (MAR index 0.50-0.62). Such resistance to a 
wide spectrum of antibiotics indicated that if isolated 
probiotics induced in patients treated with antibiotic 
therapy may be helpful in faster recovery of the 
patients due to rapid establishment of desirable 
microbial flora. Present studies have lent support the 
use of selected probiotic agents for the prevention of 
antimicrobial-associated diarrhoea. Resistance of the 
probiotic strains to some antibiotics could be used for 
both preventive and therapeutic purposes in controlling 
intestinal infections (EI-Naggar, 2004).  
 
Antibacterial activity and characterization of 
bacteriocin 
Antibacterial activity of bacteriocin produced by 
isolated probiotics showed that, L. rhamnosus (G119b), 
L. plantarum (G95a, C68a) were strong (Score 27-31) 
antibacterial than bacteriocin of commercial probiotic 
preparations Pre-Pro kid, Sporlac powder, LactoBacil 
plus, P-Biotics kid, Gastroline containing probiotics 
(Score 20-24) and standard probiotic bacterial culture 
of L. plantarum (MTCC 2621), L. rhamnosus (MTCC 
1048) (Score 20-21) against enteric bacterial 
pathogens (fig. 3). Bacteriocins of L. rhamnosus 
(G119b), L. plantarum (G95a, C68a) were stable at 
1210C and in acidic as well as alkaline pH (3 to 9). 
Moghaddam et al, (2006) reported that bacteriocins of 
L. acidophilus, L. bulgaricus were stable between pH 3 
and 10 while L. helveticus was found to be sensitive to 
pH 10. Bacteriocins of all the selected commercial 
probiotic preparations were stable at 900C and acidic to 
neutral pH i.e. (3 to 7) except P-Biotics kid was stable 
up to 1000C. Bacteriocins of standard probiotic strains 
were stable up to 1000C and pH 3 to 7. Similarly Alpay 
et al, (2003) reported that bacteriocins of Lactobacilli 
were stable at pH 4.5 to 7 but sensitive to pH 9. 
The probiotic potential based on cumulative 
probiotic score of isolated best probiotic, commercial 
probiotic preparations and standard probiotic bacterial 
strains were calculated and compared (Fig. 4).   
Probiotic potential of the isolated probiotic Lactobacilli 
is highest (100%) as compared to commercially 
available probiotic preparations (75-85%), and 
standard probiotic bacterial strains (77-81%). Different 
probiotic species and even different strains within a 
species exhibit distinctive properties. The standard 
probiotic bacterial strain, L. plantarum (MTCC 2621) 
was most efficient than L. rhamnosus (MTCC 1048). 
Among the commercial probiotic preparations Pre-Pro 
kid was found efficient probiotic followed by P-Biotics 
kid, Sporlac powder, LactoBacil plus, Gastroline, 
whereas study showed that probiotics L. plantarum 
(G95a) L. rhamnosus (G119b) from goat and L. 
plantarum (C68a) from  cow milk  were more effect 
probiotic (fig. 4). This may be due to lack of 
standardization and quality control of probiotic 
formulation, proper consistency between batches with 
respect to manufacture, storage of probiotics 
formulations (Clancy and Pang, 2007; McFarland, 
2008). Most commercial products at the time of 
purchase have low numbers of viable organisms with 
little clinical benefit. Production and quality control are 
not regulated as per the guidelines of probiotic 
products, but few products are likely to achieve the 
benefits identified in formal clinical trials. Even with 
better-characterized isolates, trial results can vary 
reflecting production and stability of the products 
(Ouwehand et al, 2003). The present study revealed 
that probiotics from goat and cow milk were acid 
tolerant at pH 2, bile tolerant at 2% bile salt, 
antibacterial against enteric pathogens, antibiotics 
resistant to most of the antibiotics and their bacteriocin 
stable at temperature 1210 C and pH 3 to 9 and strong 
antibacterial against enteric bacterial pathogens. These 
probiotics follow the criteria of FAO/WHO (2002) and 
may use to prevent the enteric bacterial infection.
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Fig. 4: Comparative study of the excellent probiotics isolated from milk of domestic animals, commercial probiotic preparations and 
standard probiotic bacterial strains 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
The present study revealed that probiotics from 
goat and cow milk, commercial probiotic and standard 
probiotic bacterial strains were acid tolerant at pH 2, 
bile salt tolerant at 2% bile salt concentration, 
antibacterial against enteric pathogens, antibiotics 
resistant to most of the antibiotics and their bacteriocin 
stable at temperature 1210C and pH 3 to 9. From 
comparative study of probiotics it was concluded that 
goat milk probiotics and their bacteriocins showed 
strong antibacterial potential as compared to the 
commercial probiotic preparation, hence probiotic from 
milk of domestic animals can be used for oral therapy 
and as prophylactic to prevent the enteric infections 
such as diarrhoea, gastroenteritis, dysentery, urinary 
tract infections, food poisoning, typhoid, irritable bowel 
syndrome etc. Study suggested that these isolated 
prominent probiotics can be used in milk or milk 
products supplement to provide restoration and 
maintenance of normal microbial flora of intestine and 
prevention of side effect of antibiotics. Study will affirm 
their use in the development of new pharmaceutical 
preparations and   functional foods that contain milk 
probiotics for the betterment of the health of the public.   
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